参考文献/References:
[1] PHILIP PW,SPEICHER L,HUMPEL C.Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas[J].Invest Ophthamlol Vis Sci,2004,41(9):2514-2522.
[2] 周兰新,李立,鄢秀菊.奥曲肽抑制角膜新生血管形成的实验研究[J].眼科新进展,2006,26(9):674-677.
ZHOU LX,LI L,YAN XJ.Octreotide inhibits corneal neovascularization induced by alkali burn[J].Rec Adv Ophthalmol,2006,26(9):674-677.
[3] 李宇,邓应平,张明,唐静,孟丹.KH902抑制大鼠角膜新生血管的实验研究[J].四川大学学报(医学版),2013,44(1):64-67.
LI Y,DENG YP,ZHANG M,TANG J,MENG D.Experimental research of KH902 inhibition of corneal neovascularization in rats[J].J Sichuan Univ(Med Sci Edit),2013,44(1):64-67.
[4] YANG J,WANG Q,QIAO C,LIN Z,LI X,HUANG Y,et al.Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody,MIL60[J].Cell Mol Immunol,2014,11(3):285-293.
[5] LU P,LI L,LIU G,VAN ROOIJEN N,MUKAIDA N,ZHANG X.Opposite roles of CCR2 and CX3CR1 macrophages in alkali-induced corneal neovascularization[J].Cornea,2009,28(5):562-569.
[6] SIMPSON DA,MURPHY GM,BHADURI T,GARDINER TA,ARCHER DB,STITT AW.Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia[J].Biochem Biophya Res Commun,1999,262(2):333-340.
[7] ZHANG SX,MA JX.Ocular neovascularization:Implication of endogenous angiogenic inhibitors and potential therapy[J].Prog Retin Eye Res,2007,26(1):1-37.
[8] DETAMR M.Molecular regulation of angiogenesis in the skin[J].Invest Dermatol,1996,106:207-208.
[9] ORMEROD LD,ABELSON MB,KENYON KR.Standard models of corneal injury using alkali-immersed filter discs[J].Invest Ophthalmol Vis Sci,1898,20(10):2148-2153.
[10] FERRARA N,GERBER HP,LECOUTER J.The biology of VEGF and its receptors[J].Nat Med,2003,9(6):669-676.
[11] KAPPAS NC,ZENG G,CHAPPELL JC,KEARNEY JB,HAZARIKA S,KALLIANOS KG,et al.The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching[J].J Cell Biol,2008,181(5):847-858.
[12] BANERJEE S,MEHTA S,HAQUE I,SENGUPTA K,DHAR K,KAMBHAMPATI S,et al.VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis[J].Biochemistry,2008,47(11):3345-3351.
[13] LEE HK,CHAUHAN SK,KAY E,DANA R.Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway[J].Blood,2011,117(21):5762-5771.
[14] KANNO S,ODA N,ABE M,TERAI Y,ITO M,SHITARA K,et al.Roles of two VEGF receptors,Flt-1 and KDR,in the signal transduction of VEGF effects in human vascular endothelial cells[J].Oncogene,2000,19(12):2138-2146.
[15] BREKKEN RA,OVERHOLSER JP,STASTNY VA,WALTENBERGER J,MINNA JD,THORPE PE.Selective inhibition of vascular endothelial growth factor(VEGF) receptor-2(KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice[J].Cancer Res,2000,60:5117-5124.
[16] ZHANG EP,MULLER A,SCHULTE F,KNIG MS,SACK F,JUNGHANS C,et al.Minimizing side effects of ballistic gene transfer into the murine corneal epithelium[J].Graefes Arch Clin Exp Ophthalmol,2002,240:114-119.
[17] 于晓晖,郝敏,康凤英.基质金属蛋白酶抑制剂在角膜疾病中的应用[J].国际眼科纵览,2006,30(1):54-57.
YU XH,HAO M,KANG FY.The application of matrix metalloproteinase inhibitors in the corneal diseases[J].Int Rev Ophthalmol,2006,30(1):54-57.
[18] CEJKA C,HOLAN V,TROSAN P,ZAJICOVA A,JAVORKOVA E,CEJKOVA J.The favorable effect of mesenchymal stem cell treatment on the antioxidant protective mechanism in the corneal epithelium and renewal of corneal optical properties changed after alkali burns[J].Oxid Med Cell Longev,2016,2016:5843809.
[19] DERYUGINA EI.Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis[J].Cancer Res,2002,62(2):580-588.
[20] BELOTTI D,PAGANONI P,MANENTI L.Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells:implications for ascites formation[J].Cancer Res,2003,63(17):5224-5229.
[21] BERGERS G,BREKKEN R,MCMAHON G,VU TH,ITOH T,TAMAKI K,et al.Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis[J].Nat Cell Biol,2000,2(10):737-744.
[22] MOHAN R,SIVAK J,ASHTON P,RUSSO LA,PHAM BQ,KASAHARA N,et al.Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2,including expression of matrix metalloproteinase gelatinase B[J].J Biol Chem,2000,275(14):10405-10412.
相似文献/References:
[1]程文武 江萍 席祖莲 张汉武 訾世莉 聂军 董彩虹.蛹虫草提取物抑制大鼠角膜新生血管的实验研究[J].眼科新进展,2012,32(5):000.
[2]于静 张明昌.苦参碱对大鼠角膜新生血管的抑制作用[J].眼科新进展,2012,32(6):000.
[3]吴正正 严京 接传红 高健生 陈皆春 宋剑涛.密蒙花方对缺氧状态下脐静脉血管内皮细胞 VEGF-VEGFR 信号转导通路的影响[J].眼科新进展,2012,32(7):000.
[4]庞霞 曲蕴慧 马跃伟 张效房 董敬民 高冬玲.去整合素金属蛋白酶9和血管内皮生长因子蛋白在眼部恶性黑色素瘤中的表达[J].眼科新进展,2012,32(7):000.
[5]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[6]许琴 黄亮 林素香 郑水华 肖煜晨 王雅丽.激光诱导小鼠脉络膜新生血管中膜攻击物与血管生长因子的表达[J].眼科新进展,2013,33(8):000.
[7]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.
[8]曾莉 常以力 邵毅.血管内皮生长因子反义寡脱氧核苷酸联合血管生成素-1对糖尿病视网膜病变大鼠视网膜血管渗漏及新生血管生成的影响[J].眼科新进展,2012,32(10):000.
[9]兰兰 惠延年 曾光伟.血管生成素-1对糖尿病大鼠视网膜微血管病变、基质金属蛋白酶和血管内皮生长因子的抑制作用[J].眼科新进展,2012,32(10):000.
[10]谢明捷 吕红彬 何跃 赵春会.炎症因子与糖尿病视网膜病变相关性研究进展[J].眼科新进展,2012,32(10):000.